Vaxart, Inc. (VXRT)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Vaxart, Inc. reported revenue of $237.26M, up 726.7% from the prior year. The company was profitable, with a net margin of 6.9%. It held $186.08M in total assets against $98.28M in total liabilities.
Key ratios (FY2025)
7.6%
Operating margin
6.9%
Net margin
18.6%
Return on equity
+726.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $237.26M | $28.70M | $7.38M | — | — | — | — | $4.16M | $5.84M | $9.30M |
| Operating Income | $18.07M | -$66.29M | -$83.35M | -$114.59M | -$72.75M | -$30.17M | -$15.79M | -$21.76M | -$10.02M | -$25.20M |
| Net Income | $16.33M | -$66.95M | -$82.47M | -$107.76M | -$70.47M | -$32.22M | -$18.64M | -$18.01M | -$9.58M | -$25.40M |
| EPS (Diluted) | $0.07 | $-0.33 | $-0.57 | $-0.84 | $-0.58 | — | — | — | $-0.76 | $-0.66 |
| Total Assets | $186.08M | $166.39M | $91.83M | $153.85M | $221.17M | $152.58M | $37.03M | $35.23M | $4.52M | $72.70M |
| Total Liabilities | $98.28M | $107.46M | $34.02M | $43.25M | $33.64M | $29.18M | $24.08M | $23.99M | $43.24M | $26.50M |
| Shareholders' Equity | $87.80M | $58.92M | $57.80M | $110.60M | $187.53M | $123.40M | $12.95M | $11.21M | -$38.72M | -$29.64M |
| Cash & Equivalents | — | — | $34.76M | $44.01M | $143.75M | — | — | $11.51M | $1.57M | $8.40M |
| Operating Cash Flow | $7.71M | -$44.76M | -$70.45M | -$94.78M | -$59.83M | -$23.75M | -$13.09M | -$14.55M | -$10.04M | — |
| Capital Expenditures | $145.0K | $554.0K | $1.87M | $9.60M | $5.16M | $1.22M | $850.0K | $707.0K | $117.0K | $200.0K |
| Shares Outstanding | 240.49M | 227.77M | 153.45M | 134.20M | 125.59M | 110.27M | 48.25M | 7.14M | 138.5K | 38.64M |